Common TitleNew Zealand Genotype 3 and 6 Trial
Official Title Efficacy of Ledipasvir and Sofosbuvir, with or without Ribavirin, for 12 Weeks inPatients with HCV Genotype 3 or 6 Infection
Phase Phase II
ClinicalTrials.gov NCT01826981
Treatments
Ledipasvir-Sofosbuvir

Ledipasvir-Sofosbuvir
Tradename:HarvoniOther Names:LDV-SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences